Intact Investment Management Inc. increased its stake in shares of Kimberly-Clark Corporation (NASDAQ:KMB – Free Report) by 617.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 66,700 shares of the company’s stock after purchasing an additional 57,400 shares during the period. Intact Investment Management Inc.’s holdings in Kimberly-Clark were worth $6,729,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its holdings in Kimberly-Clark by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 40,846,734 shares of the company’s stock worth $4,121,027,000 after purchasing an additional 315,981 shares in the last quarter. State Street Corp lifted its holdings in Kimberly-Clark by 5.0% during the 3rd quarter. State Street Corp now owns 20,830,890 shares of the company’s stock worth $2,615,382,000 after purchasing an additional 997,397 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Kimberly-Clark by 50.4% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 7,839,572 shares of the company’s stock worth $790,934,000 after purchasing an additional 2,628,206 shares in the last quarter. Capital World Investors lifted its holdings in Kimberly-Clark by 0.3% during the 3rd quarter. Capital World Investors now owns 4,940,945 shares of the company’s stock worth $614,357,000 after purchasing an additional 14,306 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in Kimberly-Clark by 0.3% during the 3rd quarter. Northern Trust Corp now owns 3,890,193 shares of the company’s stock worth $483,707,000 after purchasing an additional 9,951 shares in the last quarter. Hedge funds and other institutional investors own 76.29% of the company’s stock.
Kimberly-Clark Stock Performance
Shares of NASDAQ KMB opened at $97.67 on Monday. The stock has a market cap of $32.42 billion, a price-to-earnings ratio of 15.33, a P/E/G ratio of 4.68 and a beta of 0.29. The company has a current ratio of 0.77, a quick ratio of 0.55 and a debt-to-equity ratio of 3.38. Kimberly-Clark Corporation has a 1-year low of $92.42 and a 1-year high of $144.30. The stock’s 50-day moving average is $100.29 and its 200 day moving average is $103.46.
Insider Activity at Kimberly-Clark
In related news, insider Katy Chen sold 1,405 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $96.95, for a total transaction of $136,214.75. Following the transaction, the insider directly owned 6,502 shares in the company, valued at $630,368.90. This trade represents a 17.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, VP Andrew Scribner sold 3,049 shares of the firm’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $104.29, for a total value of $317,980.21. The disclosure for this sale is available in the SEC filing. 0.75% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
KMB has been the topic of a number of recent research reports. Zacks Research cut Kimberly-Clark from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 3rd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kimberly-Clark in a research report on Friday, March 27th. UBS Group lifted their target price on shares of Kimberly-Clark from $105.00 to $106.00 and gave the company a “neutral” rating in a research report on Wednesday. Bank of America dropped their target price on shares of Kimberly-Clark from $130.00 to $120.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Finally, Citigroup dropped their target price on shares of Kimberly-Clark from $95.00 to $90.00 and set a “sell” rating for the company in a research report on Wednesday, January 14th. Four equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $114.93.
Check Out Our Latest Analysis on KMB
Kimberly-Clark Profile
Kimberly-Clark Corporation is a U.S.-based multinational manufacturer of personal care and consumer tissue products. The company develops, produces and markets a range of consumer brands and professional products, including facial and bathroom tissues, disposable diapers and training pants, feminine care, incontinence products and workplace hygiene solutions. Known for consumer-facing names such as Kleenex, Huggies, Kotex, Cottonelle and Scott, as well as professional offerings under Kimberly-Clark Professional and KleenGuard, the company supplies goods to retail, healthcare and institutional customers.
Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark has expanded from its 19th-century paper-making roots into a global household and workplace products company.
Featured Articles
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Corporation (NASDAQ:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.
